Domainex's newsletter brings you up to speed on the latest announcements from the team.

No images? Click here

Domainex - Enrich your medicines pipeline
 

Domainex newsletter

All the latest news and industry insights from the Domainex team

 
 
 
Tom headshot

Tom Mander, CEO

Springing into the new season

Spring is officially here, and I hope you are all looking forward to the season of new beginnings. Speaking of which, Domainex has recently opened a new facility to expand its research operations in Cambridge’s newest science and technology park, Unity Campus. Along with this, we’ve also announced the purchase of over £1M worth of new equipment to expand our analytical chemistry, bioanalytical sciences and ADME capabilities.

These announcements follow over two years of very strong growth for Domainex – which is why we’ve recruited so many new team members recently and plan to continue recruiting to increase our headcount by up to fifty per cent by the end of this year. I very much look forward to seeing our latest investments and expanding team support new and existing partners over the next few months.

I hope you all have a great spring.

 
New facility image

Domainex opens a dedicated new facility at Unity Campus to expand research operations

Domainex has opened a new Biology Centre of Excellence of over 7,000 sq ft at Unity Campus in Sawston, Cambridge’s newest science and technology park. This Centre is fully operational and from it we are undertaking protein expression and X-ray crystallography, as well as running biochemical, biophysical and cellular assays to support each stage of drug discovery. It consolidates the Company’s footprint in the Cambridge bioscience cluster.

Read the full article
 
Waters equipment image
 

Domainex expands analytical chemistry capabilities with over £1M worth of new Waters equipment

Domainex has purchased over £1M worth of new Waters equipment to enhance its capabilities in analytical chemistry, bioanalytical sciences and in vitro absorbance, distribution, metabolism, and excretion (ADME) assays. 

 
Robina headshot
 

Meet the Domainex Team: Robina Akhtar

For International Women’s Day, Domainex’s Financial Controller Robina Akhtar tells us about the challenges she’s faced throughout her career and how the industry is changing for women.

 
World Cancer Day graphic
 

World Cancer Day

Domainex explores the role of a contract research organisation (CRO) in the fight against cancer.

 
Ian headshot
 

Meet the Domainex Team: Ian Winfield

Ian tells us about his role at Domainex as Team Leader for Assay Biology and explores his career to date.

 
New recuits graohic
 

New recruits

Welcome to Andrew Jones (Senior Scientist I, Chemistry), George Phillips (Scientist, Chemistry), Jake Stewart (Scientist, Analytical Chemistry), Ryan Bentley (Facilities and Laboratory Manager), Satya Prathyusha (Senior Scientist II, Protein Science) and Sebastian Schwenk (Senior Scientist II, Chemistry) who have all recently joined the Domainex team. If you are interested in joining these new members of staff at Domainex, visit our website to view the current available opportunities.

New publications

Medicinal Chemistry in Review: Identification of MRTX1133, a Noncovalent, Potent and Selective KRAS Inhibitor

Synthesis in Review: Highly useful synthetic transformations to accelerate the drug discovery process and achieve previously challenging reactions

Medicinal Chemistry in Review: BACE1 Inhibitors as a Treatment for Alzheimer’s Disease

Upcoming events

European SMALP meeting
6th-8th April 2022 | Birmingham, UK
Exploring the latest developments within the field of styrene-maleic acid lipid particles (SMALPs), bringing together a wide range of researchers to share their findings.

BioTrinity
26th-27th April 2022 | London, UK
A conference that catalyses growth and supports in-person re-engagement across the life sciences industry.

33rd Medicinal Chemistry in Eastern England
28th April 2022 | Hatfield, UK
Sponsored by Domainex, this event comprises of presentations showcasing medicinal chemistry case studies. Dr Nick Martin, Associate Principal Scientist at Domainex, will be presenting a talk entitled "Development of MAP4K4 Inhibitors for the Suppression of Cardiac Muscle Cell Death".

Start your next project with Domainex

Contact one of our experts today
 
 
  Share 
  Tweet 
  Share 
  Forward 
Domainex is a registered company (number 4336899)
Chesterford Research Park
Little Chesterford
Saffron Walden, Essex
CB10 1XL, UK
Preferences  |  Unsubscribe